Abstracts
Gastrointestinal tumours, non-colorectal
152O - Efficacy and safety of the Met inhibitor tepotinib in patients (pts) with advanced Met+ hepatocellular carcinoma (HCC) previously treated with sorafenib

https://doi.org/10.1093/annonc/mdy432.004Get rights and content
Under an Elsevier user license
open archive

Cited by (0)